Brief: Cytosorbents Provides U.S. FDA And Health Canada Regulatory Update For Drugsorb-Atr
02/07/2025 12:20
July 2 (Reuters) - Cytosorbents Corp CTSO.O: CYTOSORBENTS PROVIDES U.S. FDA AND HEALTH CANADA REGULATORY UPDATE FOR DRUGSORB-ATR CYTOSORBENTS CORP - FDA SCHEDULES APPEAL HEARING DATE FOR DRUGSORB-ATR CYTOSORBENTS CORP - FDA REVIEW PROCESS EXPECTED TO COMPLETE BY END OF AUGUST 2025 CYTOSORBENTS CORP - HEALTH CANADA ISSUES NOTICE OF REFUSAL FOR DRUGSORB-ATR CYTOSORBENTS CORP - TO FILE REQUEST FOR RECONSIDERATION WITH HEALTH CANADA Source text: ID:nPn2DzgFDa Further company coverage: CTSO.O (((( Reuters.briefs@thomsonreuters.com ;));))